Table 4.
Criteria met | Sensitivity | 95 % CI | Specificity | 95 % CI | PPV | NPV |
---|---|---|---|---|---|---|
Single criteria | ||||||
1. Percentage LV- MMnon-compacted > 25 % | 91 | 62.3–98.4 | 100 | 92.1–100 | 100 | 98 |
(10/11) | (45/45) | (10/10) | (45/46) | |||
2. Total LV-MMInon-compacted > 15 g/m2 | 91 | 62.3–98.4 | 91 | 79.3–96.5 | 71 | 98 |
(10/11) | (41/45) | (10/14) | (41/42) | |||
3. Cut-off ≥ 3:1 (segment 17 excluded) | 100 | 75.8–100 | 93 | 82.1–97.7 | 80 | 100 |
(12/12) | (42/45) | (12/15) | (42/42) | |||
4. Trabeculation in segments 4–6 ≥ 2:1 | 67 | 39.1–86.2 | 91 | 79.3–96.5 | 67 | 91 |
(8/12) | (41/45) | (8/12) | (41/45) | |||
Cut-off ≥ 3:1 (segment 17 included) | 100 | 75.8–100 | 73 | 59.0–84.1 | 50 | 100 |
(12/12) | (33/45) | (12/24) | (33/33) | |||
Cut-off > 2.3:1 (segment 17 excluded) | 100 | 75.8–100 | 80 | 66.2–89.1 | 57 | 100 |
(12/12) | (36/45) | (12/21) | (36/36) | |||
Cut-off > 2.3:1 (segment 17 included) | 100 | 75.8–100 | 58 | 43.3–71.0 | 39 | 100 |
(12/12) | (26/45) | (12/31) | (19/19) | |||
Combined criteria (1–4) | ||||||
Two of four criteria (1–4) | 100 | 75.8–100 | 95 | 85.2–98.8 | 86 | 100 |
(12/12) | (43/45) | (12/14) | (43/43) | |||
Three of four criteria (1–4) | 92 | 64.6–98.5 | 100 | 92.1–100 | 100 | 96 |
(11/12) | (45/45) | (9/9) | (45/48) | |||
Four of four criteria (1–4) | 75 | 46.8–91.1 | 100 | 92.1–100 | 100 | 94 |
(9/12) | (45/45) | (7/7) | (45/49) |
Sensitivity and specificity data are presented as percentage with number of related patients in parenthesis
CI confidence interval, PPV positive predictive value, NPV negative predictive value